Testing VNX001 for bladder pain syndrome
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new treatment (VNX001) for people with interstitial cystitis or bladder pain syndrome (IC/BPS). You must have already taken part in an earlier study of this drug to join. The goal is to see if it safely reduces bladder pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You already completed a previous study of VNX001.
- You are 18 or older.
- You have had bladder pain for at least 9 months.
- You have had a cystoscopy (a scope test of your bladder) in the last year for your diagnosis.
- Your bladder pain is at least moderately severe right now (score 4 or more out of 11) shortly after urinating.
- If you are a woman who could become pregnant, you must use reliable birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests VNX001 to see if it helps people with interstitial cystitis/bladder pain syndrome (IC/BPS) compared with its separate ingredients (lidocaine and heparin) or a placebo (inactive treatment). You may be eligible if you have had IC/BPS for months and recently had a moderate-to-severe bladder pain flare.
This study is testing if the type of pain you feel can help predict which treatments work best for interstitial cystitis (a condition that causes bladder pain and pressure). It may help match you with more effective care.
This trial tests whether acupuncture can help relieve pain and pressure from bladder pain syndrome (also called interstitial cystitis). Researchers want to see if using acupuncture early can improve symptoms better than usual care.
This study looks for genetic (inherited) causes of bladder pain syndrome (IC/BPS), using information from people who have typical urinary symptoms. It may help doctors understand why IC/BPS happens, which could guide better future care.
This trial tests whether the antidepressant venlafaxine, combined with education and behavior changes, can reduce pain and urinary urgency in people with bladder pain syndrome (interstitial cystitis).
This study tests a new treatment for women with interstitial cystitis (also called painful bladder syndrome) who have Hunner's lesions (specific sores in the bladder lining). The goal is to see if the new treatment can reduce pelvic pain, frequent urination, and other symptoms.
Hear when a new Interstitial Cystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.